Ron Cohen
2013
Compensation breakdown
Non-Equity Incentive Plan | $527,800 |
---|---|
Option Awards | $1,976,389 |
Salary | $720,833 |
Stock Awards | $685,350 |
Other | $7,650 |
Total | $3,918,022 |
Cohen received $2M in option awards, accounting for 50% of the total pay in 2013.
Cohen also received $527.8K in non-equity incentive plan, $720.8K in salary, $685.4K in stock awards and $7.7K in other compensation.
Rankings
In 2013, Ron Cohen's compensation ranked 1,810th out of 12,286 executives tracked by ExecPay. In other words, Cohen earned more than 85.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,810 | 85th |
Manufacturing | 589 | 87th |
Chemicals And Allied Products | 159 | 89th |
Drugs | 108 | 91st |
Biological Products, Except Diagnostic Substances | 13 | 93rd |
Cohen's colleagues
We found six more compensation records of executives who worked with Ron Cohen at Acorda Therapeutics in 2013.
2013
Michael Rogers
Acorda Therapeutics
Chief Financial Officer
2013
Jane Wasman
Acorda Therapeutics
General Counsel
2013
Enrique Carrazana
Acorda Therapeutics
Chief Medical Officer
2013
Andrew Blight
Acorda Therapeutics
Chief Scientific Officer
2013
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2013
David Lawrence
Acorda Therapeutics
Chief Financial Officer
News
April 27, 2023
April 28, 2022
April 23, 2021
April 28, 2020
April 26, 2019